Login to Your Account



Financings Roundup


Wednesday, February 2, 2011
Savient Pharmaceuticals Inc., of East Brunswick, N.J., has priced $200 million of convertible senior notes. Underwriters have an option to purchase up to an additional $30 million of notes to cover overallotments.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription